A Phase II Study of Docetaxel and Carboplatin as Neoadjuvant Therapy for Nasopharyngeal Carcinoma with Early T Status and Advanced N Status

Faye M. Johnson, Adam Garden, J. Lynn Palmer, Merrill Kies, Gary Clayman, Brenda Brumfield, Fadlo R. Khuri, William Morrison, Vassiliki Papadimitrakopoulou, Eduardo M. Diaz, Bonnie S. Glisson

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Study of Docetaxel and Carboplatin as Neoadjuvant Therapy for Nasopharyngeal Carcinoma with Early T Status and Advanced N Status'. Together they form a unique fingerprint.

Medicine & Life Sciences